Healthtech SaaS startup Doceree has secured $35 million in its Series B funding round, with Creageis as the main investor, alongside existing backers Eight Roads Ventures and F-Prime Capital.
The company plans to use this fresh funding to speed up product development, enhance its technology, expand globally, and increase its workforce.
Founded by Harshit Jain and Daleep Manhas in 2018, Doceree simplifies marketing for pharmaceutical and medical device companies. It offers a platform for healthcare professionals (HCPs) to engage in programmatic messaging using proprietary tools. This platform connects life sciences brands with HCPs across digital endemic and point-of-care platforms, allowing for personalized communication at scale.
After establishing a presence in the US, India, and Europe, Doceree has expanded to Africa, Southeast Asia, and the Gulf Cooperation Council (GCC).
The startup has plans to launch new products in the near future, aiming to transform the global healthcare ecosystem.
In a previous Series A funding round last year, Doceree raised $11 million, with Eight Roads Ventures, F-Prime Capital, and Alkemi Growth Capital participating.
Doceree is focusing on investing in artificial intelligence and machine learning technologies to enhance its platform. One of its key technologies, ESPYIAN, is an identity resolution platform that creates a database of verified medical and healthcare professionals.
Creageis, the lead investor in Doceree’s recent funding round, recently closed a $425 million fund to support domestic startups.